300 related articles for article (PubMed ID: 21492259)
41. Nonpurulent response to toxic shock syndrome toxin 1-producing Staphylococcus aureus. Relationship to toxin-stimulated production of tumor necrosis factor.
Fast DJ; Schlievert PM; Nelson RD
J Immunol; 1988 Feb; 140(3):949-53. PubMed ID: 3339245
[TBL] [Abstract][Full Text] [Related]
42. Llama heavy-chain antibody fragments efficiently remove toxic shock syndrome toxin 1 from plasma in vitro but not in experimental porcine septic shock.
Brummelhuis WJ; Joles JA; Stam JC; Adams H; Goldschmeding R; Detmers FJ; El Khattabi M; Maassen BT; Verrips CT; Braam B
Shock; 2010 Aug; 34(2):125-32. PubMed ID: 20016410
[TBL] [Abstract][Full Text] [Related]
43. Structural basis of superantigen action inferred from crystal structure of toxic-shock syndrome toxin-1.
Acharya KR; Passalacqua EF; Jones EY; Harlos K; Stuart DI; Brehm RD; Tranter HS
Nature; 1994 Jan; 367(6458):94-7. PubMed ID: 8107781
[TBL] [Abstract][Full Text] [Related]
44. Persistence survey of toxic shock syndrome toxin-1 producing Staphylococcus aureus and serum antibodies to this superantigen in five groups of menstruating women.
Parsonnet J; Hansmann MA; Seymour JL; Delaney ML; Dubois AM; Modern PA; Jones MB; Wild JE; Onderdonk AB
BMC Infect Dis; 2010 Aug; 10():249. PubMed ID: 20731864
[TBL] [Abstract][Full Text] [Related]
45. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.
Bohach GA; Fast DJ; Nelson RD; Schlievert PM
Crit Rev Microbiol; 1990; 17(4):251-72. PubMed ID: 2206394
[TBL] [Abstract][Full Text] [Related]
46. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
von Bonin A; Ehrlich S; Malcherek G; Fleischer B
Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
[TBL] [Abstract][Full Text] [Related]
47. The bacterial superantigen and superantigen-like proteins.
Fraser JD; Proft T
Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785
[TBL] [Abstract][Full Text] [Related]
48. Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal Environment.
Dufresne K; Podskalniy VA; Herfst CA; Lovell GFM; Lee IS; DeJong EN; McCormick JK; Tuffs SW
J Bacteriol; 2022 Oct; 204(10):e0026922. PubMed ID: 36106854
[TBL] [Abstract][Full Text] [Related]
49. Immune response to toxic-shock-syndrome toxin-1 (TSST-1) and to staphylococcal enterotoxins A, B and C in Staphylococcus aureus infections.
Kunstmann G; Schröder E; Hasbach H; Pulverer G
Zentralbl Bakteriol; 1989 Oct; 271(4):486-92. PubMed ID: 2818798
[TBL] [Abstract][Full Text] [Related]
50. Staphylococcal toxic shock syndrome: superantigen-mediated enhancement of endotoxin shock and adaptive immune suppression.
Kulhankova K; King J; Salgado-Pabón W
Immunol Res; 2014 Aug; 59(1-3):182-7. PubMed ID: 24816557
[TBL] [Abstract][Full Text] [Related]
51. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
52. Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1.
Micusan VV; Desrosiers M; Gosselin J; Mercier G; Oth D; Bhatti AR; Heremans H; Billiau A
Rev Infect Dis; 1989; 11 Suppl 1():S305-12. PubMed ID: 2494690
[TBL] [Abstract][Full Text] [Related]
53. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
Schlievert PM
Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
[TBL] [Abstract][Full Text] [Related]
54. Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vbeta-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes.
Davison S; Allen M; Vaughan R; Barker J
Clin Exp Immunol; 2000 Aug; 121(2):181-6. PubMed ID: 10931129
[TBL] [Abstract][Full Text] [Related]
55. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period.
Takahashi N; Nishida H; Kato H; Imanishi K; Sakata Y; Uchiyama T
Lancet; 1998 May; 351(9116):1614-9. PubMed ID: 9620715
[TBL] [Abstract][Full Text] [Related]
56. Immune response to staphylococcal superantigens.
Krakauer T
Immunol Res; 1999; 20(2):163-73. PubMed ID: 10580640
[TBL] [Abstract][Full Text] [Related]
57. Cytotoxicity of lymphocytes activated by superantigen toxic-shock-syndrome toxin-1 against colorectal cancer LoVo cells.
Wang W; Sun X; Lu L; Zheng JB; Tian Y; Wang W
Mol Cell Biochem; 2013 Apr; 376(1-2):1-9. PubMed ID: 23340976
[TBL] [Abstract][Full Text] [Related]
58. Upregulation of IgE synthesis by staphylococcal toxic shock syndrome toxin-1 in peripheral blood mononuclear cells from patients with atopic dermatitis.
Hofer MF; Lester MR; Schlievert PM; Leung DY
Clin Exp Allergy; 1995 Dec; 25(12):1218-27. PubMed ID: 8821303
[TBL] [Abstract][Full Text] [Related]
59. Inverse relationship between toxic shock syndrome toxin-1 antibodies and interferon-γ and interleukin-6 in peripheral blood mononuclear cells from patients with pediatric tonsillitis caused by Staphylococcus aureus.
Chen Y; Huang Y; Liang B; Dong H; Yao S; Xie Y; Long Y; Zhong H; Yang Y; Zhu B; Gong S; Zhou Z
Int J Pediatr Otorhinolaryngol; 2017 Jun; 97():211-217. PubMed ID: 28483238
[TBL] [Abstract][Full Text] [Related]
60. High Titer Persistent Neutralizing Antibodies Induced by TSST-1 Variant Vaccine Against Toxic Shock Cytokine Storm.
Roetzer A; Stich N; Model N; Schwameis M; Firbas C; Jilma B; Eibl MM
Toxins (Basel); 2020 Oct; 12(10):. PubMed ID: 33023185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
